GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 172 filers reported holding GW PHARMACEUTICALS PLC in Q2 2017. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $2,000 | +100.0% | 14 | 0.0% | 0.00% | – |
Q3 2020 | $1,000 | 0.0% | 14 | +40.0% | 0.00% | – |
Q4 2017 | $1,000 | 0.0% | 10 | 0.0% | 0.00% | – |
Q3 2017 | $1,000 | 0.0% | 10 | 0.0% | 0.00% | – |
Q2 2017 | $1,000 | 0.0% | 10 | 0.0% | 0.00% | -100.0% |
Q1 2017 | $1,000 | -88.9% | 10 | -88.2% | 0.00% | -83.3% |
Q4 2016 | $9,000 | – | 85 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VHCP Management, LLC | 311,853 | $25,213,000 | 11.33% |
Iguana Healthcare Management, LLC | 50,000 | $4,043,000 | 2.16% |
Ghost Tree Capital, LLC | 35,000 | $2,830,000 | 1.54% |
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 354,278 | $28,643,000 | 1.06% |
Cupps Capital Management, LLC | 100,213 | $8,102,000 | 0.75% |
CLOUGH CAPITAL PARTNERS L P | 192,600 | $15,572,000 | 0.58% |
FARALLON CAPITAL MANAGEMENT LLC | 244,000 | $19,727,000 | 0.32% |
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 105,200 | $8,505,000 | 0.31% |
Eventide Asset Management | 25,000 | $2,021,000 | 0.28% |
PRUDENTIAL PLC | 836,124 | $67,601,000 | 0.28% |